CESAR PINA: Open Payments
NPI 1134530462 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$734 in 6 payments from 4 companies in 2025. Trend: 2023 $242 · 2024 $374 · 2025 $734
Food & beverage: $734
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 2 | $245 |
| Teva Pharmaceuticals USA, Inc. | 2 | $234 |
| Alkermes, Inc. | 1 | $130 |
| Neurocrine BioSciences, Inc. | 1 | $124 |
Products named: COBENFY, UZEDY, LYBALVI, INGREZZA.
Industry payments across TX — which companies pay providers there.
